Upregulating the expression of HSPB6 and TCF7L1 effectively inhibits the proliferation, migration, invasion, and overall growth of BLCA cells, thereby impeding the development of BLCA. The gene discussed is TCF7L1; the disease is bladder transitional cell carcinoma.